Skip to main content
TipRanks
Go Ultimate75% OFF

EnBio Holdings, Inc. (6092) AI Stock Analysis

0 Followers
JP:6092

EnBio Holdings, Inc.

(TSE/TYO:6092)

Select Model
Rating:38Underperform
Price Target:JPY 581.00â–¼(-6.29% Downside)
Action:downgraded
Date:11/18/26

The overall score is very low, driven primarily by weak financial performance and bearish technicals. The company's inability to convert strong revenue growth into net income and cash flow is a major concern. This is compounded by a stock price in a clear downtrend, trading below all key moving averages with deeply oversold momentum. The high P/E ratio adds further downside risk given the earnings deterioration.

Positive Factors
Revenue GrowthRevenue growth of 24.94% in 2026, following 11.41% in 2025, indicates sustained demand expansion rather than a single-period increase. A growing top line can broaden the company’s operating base and create greater opportunity to leverage fixed capabilities, provided profitability stabilizes.
Negative Factors
Profitability DeteriorationProfitability has weakened materially even as revenue grows, with net margin falling to about 2.10% and net income declining in 2026. This suggests that cost, pricing, or mix pressures are absorbing sales gains, reducing earnings resilience and limiting the benefits of continued expansion.

EnBio Holdings, Inc. (6092) vs. iShares MSCI Japan ETF (EWJ)

-10%0%10%20%30%40%50%60%JP:6092+4.53%EWJ+15.53%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 4.91B
Dividend Yield
1.45%
Average Volume (3M)
22.98K
Price to Earnings (P/E)
42.9
Beta (1Y)
0.51
Revenue Growth
22.25%
EPS Growth
-80.27%
Country
Japan
Employees
113
Sector
Industrials
Sector Strength
63
Industry
Environmental Services

EnBio Holdings, Inc. Business Overview & Revenue Model

Company Description

EnBio Holdings, Inc. engages in the provision of soil pollution countermeasure services. It operates through the following segments: Soil Pollution Countermeasures, Brownfield Utilization, and Natural Energy. The Soil Pollution Countermeasures segmen...

How the Company Makes Money

null

EnBio Holdings, Inc. Financial Statement Overview

Summary

Financial performance is weak. While revenue growth is strong, net margin has collapsed to 2.1% and free cash flow is minimal at ¥119 million. The Income Statement (38), Balance Sheet (45), and Cash Flow (32) scores all reflect significant profitability and cash generation concerns.

Income Statement

38Negative

Balance Sheet

45Neutral

Cash Flow

32Negative
Financial statement breakdown
BreakdownTTMMar 2026Mar 2026Mar 2025Mar 2024Mar 2023
Income Statement
Total Revenue10.39B10.67B12.63B9.58B8.12B8.99B
Gross Profit2.67B2.65B3.69B2.48B2.76B2.43B
EBITDA1.26B1.35B2.16B1.25B1.76B1.59B
Net Income579.86M452.69M265.00M708.76M812.06M654.06M
Balance Sheet
Total Assets22.24B21.20B22.85B19.31B17.35B16.37B
Cash, Cash Equivalents and Short-Term Investments3.76B3.29B4.04B3.60B2.83B2.37B
Total Debt10.29B10.10B10.65B8.62B8.90B8.58B
Total Liabilities12.75B11.96B13.52B10.72B10.49B10.40B
Stockholders Equity9.41B9.14B9.25B8.49B6.79B5.89B
Cash Flow
Free Cash Flow0-1.44B119.00M584.36M826.37M1.25B
Operating Cash Flow021.92M1.17B1.66B1.99B2.41B
Investing Cash Flow0-1.60B-891.00M-1.58B-1.77B-1.48B
Financing Cash Flow01.27B460.00M638.92M240.73M-534.92M

EnBio Holdings, Inc. Technical Analysis

Technical Analysis SentimentNegative
Last Price620.00

Price Trends

50DMA772.12Negative
100DMA765.58Negative
200DMA755.32Negative

Market Momentum

MACD-31.95Positive
RSI25.57Positive
STOCH5.80Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6092, the sentiment is Negative. The current price of 620.00 is below the 20-day moving average (MA) of 739.30, below the 50-day MA of 772.12, and below the 200-day MA of 755.32, indicating a bearish trend. The MACD of -31.95 indicates Positive momentum. The RSI at 25.57 is Positive, neither overbought nor oversold. The STOCH value of 5.80 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:6092.

EnBio Holdings, Inc. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (63)

Financial Indicators

JP:6092 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:7987JP:798768NeutralJPY 13.82B5.57―4.11%-0.27%41.12%
JP:9325JP:932567NeutralJPY 10.88B9.19―3.40%20.43%35.08%
JP:7049JP:704965NeutralJPY 5.86B-29.80――-13.95%-133.99%
JP:9791JP:979164NeutralJPY 8.03B6.08―3.57%0.94%6.37%
Sector *63Neutral$10.79B15.437.44%2.01%2.89%-14.66%
JP:4809JP:480961NeutralJPY 18.99B7.89―3.85%7.06%15.39%
JP:6092JP:609238UnderperformJPY 5.05B42.89―1.45%22.25%-80.27%

* Industrials Sector Average

Performance Comparison

0%20%40%JP:6092JP:4809JP:7049JP:7987JP:9325JP:9791Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:6092 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:6092EnBio Holdings, Inc.620.0029.835.05%
JP:4809Paraca Inc.1871.00-125.08-6.27%
JP:7049SHIKIGAKU Co., Ltd.695.00-154.00-18.14%
JP:7987Nakabayashi Co., Ltd.535.0010.201.94%
JP:9325PHYZ Holdings, Inc.1000.00-8.62-0.85%
JP:9791Biken Techno Corporation1065.00-172.51-13.94%

EnBio Holdings, Inc. Corporate Events

EnBio Holdings Reports Six-Month Consolidated Results

Nov 13, 2026

EnBio Holdings, Inc. reported consolidated results for the six months ended September 30, 2026. Net sales increased 1.3% year over year to ¥5,756 million, operating profit rose 8.6% to ¥712 million, and ordinary profit grew 7.3% to ¥642 million, whil...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 18, 2026